Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical ...

India's contract drug makers have urged the government to remove regulatory hurdles and grant faster clearance to vital raw ...

India's CRDMO sector is projected to reach US$ 25 billion by 2035, driven by cost advantages, fast project startups, and growing biologics expertise, strengthening its global pharma innovation role.

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's ...

India's contract drug makers have urged the government to remove regulatory hurdles and grant faster clearance to vital raw ...

The debate on MSCs, mesenchymal stromal cells versus mesenchymal stem cells, continued for more than two decades (since 2006), being the major obstacle for MSCs study and clinical application. The ...

KØBENHAVN, DENMARK / ACCESS Newswire / February 27, 2025 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark, 27 February 2025 - FluoGuide A/S ("FluoGuide" or the "Company") hereby publishes its annual ...

China's Baidu and electric vehicle battery giant CATL will jointly explore the development of "competitive" driverless ...

Egg prices are expected to continue surging in 2025, ending the year 41.1% higher than at the end of 2024. The American pro ...